Expertise in
4
conditions

Farkhad Manapov

Munich, BY, DE 
Expertise in
4
conditions
Munich, BY, DE 

Overview

Farkhad Manapov practices practicing medicine in Munich, Germany.

Manapov is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Metastases.

They are actively involved in clinical research, co-authoring 131 peer reviewed articles and participating in 1 clinical trial.

Locations

Munich, BY, Germany
Other Locations
Guenzburg, BY, Germany
Giessen, HE 35392, Germany
Germany
Maximilian, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab (PRECISION)
Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab (PRECISION)
Enrollment Status: Unknown
Publish Date: March 08, 2023
Intervention Type: Other

131 Total Publications

Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320).
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320).
Journal: JAMA oncology
Published: July 09, 2026

Frequently Asked Questions about Farkhad Manapov

Is Farkhad Manapov a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Farkhad Manapov is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Farkhad Manapov participate in research or clinical trials?

Yes. Farkhad Manapov has published 131 articles and abstracts on conditions like Lung Cancer. You can view a list of Farkhad Manapov's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Manapov's expertise for a condition
ConditionClose
View All 15 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile